Wei-Chung Chang

Title: Innovations of Wei-Chung Chang

Introduction

Wei-Chung Chang is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of pharmaceutical compositions and imaging technologies. With a total of two patents to his name, his work focuses on the intersection of cannabinoid and estrogen receptors, as well as tumor imaging and therapy.

Latest Patents

Wei-Chung Chang's latest patents include a composition for cross talk between estrogen receptors and cannabinoid receptors. This composition features a chelator and a receptor ligand, and it provides a method for synthesizing the composition. The composition can be further developed into pharmaceutical formulations or kits for therapeutic use or molecular imaging. His second patent involves a compound and pharmaceutical composition for tumor imaging and therapy. This compound, represented by a specific formula, demonstrates higher specificity to tumor cells, making it suitable for delivering anti-cancer drugs and nuclear imaging agents.

Career Highlights

Wei-Chung Chang is currently associated with Seecure Taiwan Co., Ltd. His innovative work has positioned him as a key figure in the development of advanced therapeutic solutions. His patents reflect a commitment to enhancing medical treatments and imaging techniques.

Collaborations

Wei-Chung Chang has collaborated with notable colleagues, including Tsung-Tien Kuo and David J Yang. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Wei-Chung Chang's contributions to the fields of pharmacology and imaging are noteworthy. His innovative patents demonstrate a commitment to improving therapeutic options for patients. His work continues to influence the landscape of medical research and development.